Skip to content

Laryngeal Mask Airway (LMA) Protector for Minimally Invasive Thyroidectomy

Study of the Laryngopharyngeal Symptoms After Minimally Invasive Thyroidectomy: Comparison Between the Protector Laryngeal Mask Airway and the Endotracheal Tube.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03098667
Enrollment
79
Registered
2017-04-04
Start date
2017-02-01
Completion date
2017-11-01
Last updated
2017-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sore Throat, Dysphagia, Postoperative Pain

Brief summary

The patients will be allocated to 2 groups: the LMA group and the endotracheal tube (ET) group. Airway management will be done with the LMA Protector for the patients of the LMA group and with the classic endotracheal tube for the patients of the ET group. The main purpose of the study is to determine if the application of the LMA Protector causes less laryngopharyngeal symptoms than the endotracheal tube after minimally invasive thyroidectomy. The secondary purpose is to confirm that the LMA Protector is a safe alternative airway management device for minimally invasive thyroidectomy.

Interventions

After induction of general anesthesia, the LMA Protector will be applied for airway management. The size of the laryngeal mask will be chosen according to the manufacturer's instructions. Lubricant gel will be applied to the dorsal side of the mask to ease the insertion to the oropharynx. The cuff of the mask will be filled with air by syringe until the indication of the integrated cuff pressure indicator is appropriate according to the manufacturer (green indication). If the indication changes during surgery, air will be added or removed accordingly. If the ventilation of the patient is inadequate at the beginning or anytime during the operation, the mask will be removed and the patient will be intubated.

DEVICEEndotracheal tube

After induction of general anesthesia, the endotracheal tube be applied for airway management. The size of the tube will be 7.5 for female and 8.5 for male patients. The cuff of of the tube will be filled with 10ml air.

Sponsors

424 General Military Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Total thyroidectomy with the minimally invasive method. * American Society of Anesthesiologists (ASA) classification 1-3

Exclusion criteria

* Clinical conditions which cause any kind of airway obstruction or compromise. * Tracheal displacement greater than 2cm from midline. * History of gastroesophageal reflux disease. * Expected difficult airway. * History of impossible intubation. * BMI\>35 * Reoperation within 24hours.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative sore throat.Within 20 minutes from the end of the procedure.The patients will be asked to evaluate their postoperative constant pharyngeal pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
Postoperative surgical site pain.Within 20 minutes from the end of the procedure.The patients will be asked to evaluate their postoperative surgical trauma pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
Postoperative dysphagia.Within 20 minutes from the end of the procedure.The patients will be asked to evaluate their postoperative pharyngeal pain caused after swallowing one sip of water by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).

Secondary

MeasureTime frameDescription
Postoperative paracetamol consumption.1, 6, 12 and 24 hours after emergence from general anesthesia.The patients will be instructed to ask for analgesics as needed. When rescue analgesia is required 1000mg paracetamol will be administered. The frequency of paracetamol administration will be documented.
Airway management difficulty.3 minutes after induction of general anesthesia.The efforts required to establish a secure airway and manage adequate patient ventilation will be recorded.
Postoperative hoarseness.Within 20 minutes from the end of the procedure and after 1, 6, 12 and 24 hours.The patients postoperative hoarseness will be evaluated according to the GRBAS scale.
Airway management complications.Within 5 minutes from induction of general anesthesia.Any complication from airway management will be recorded like bleeding from the stomatopharynx or the larynx, tooth trauma, lip trauma, etc.
Emergence coughing.Within 10 minutes from the end of the surgery.The incidence of cough upon emergence from general anesthesia will be recorded.

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026